TITLE

Does long term aspirin prevent cancer?

AUTHOR(S)
Moayyedi, Paul; Jankowski, Janusz A.
PUB. DATE
January 2011
SOURCE
BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/1/2011, Vol. 342 Issue 7787, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors discuss a meta-analysis of randomized controlled trials (RCTs) on the use of aspirin to reduce the risk of non-fatal myocardial infarction, by Rothwell and colleagues, published in the 2010 issue of "Lancet." The meta-analysis found that cancer patients who took aspirin for almost six years have 21 percent lower mortality rates than those who did not. The authors comment on the methods used by Rothwell and colleagues in their meta-analysis. They argue that data on aspirin use is not yet sufficient to recommend it for the general population.
ACCESSION #
57319660

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics